Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 4 (2007), Issue 6 (June)

1. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.
   Am J Psychiatry, 164(6): 916-21. [Abstract] [Full-text]
2. Nursing home placement, day care use, and cognitive decline in Alzheimer's disease.
   Am J Psychiatry, 164(6): 910-5. [Abstract] [Full-text]
3. Turning back the clock on neurodegeneration.
   Cell, 129(5): 851-3. [Abstract] [Full-text]
4. Anterior opercular syndrome in frontotemporal lobar degeneration with ubiquitin-only immunoreactive neuronal changes.
   Eur J Neurol, 14(6): 697-700. [Abstract] [Full-text]
5. Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness.
   Eur J Neurol, 14(6): 690-3. [Abstract] [Full-text]
6. What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia?
   Eur J Neurol, 14(6): 679-82. [Abstract] [Full-text]
7. Polymorphisms at codons 129 and 219 of the prion protein gene (PRNP) are not associated with sporadic Alzheimer's disease in the Korean population.
   Eur J Neurol, 14(6): 621-6. [Abstract] [Full-text]
8. Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline.
   Psychopharmacology (Berl), 192(4): 547-53. [Abstract] [Full-text]
9. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
   Neurobiol Aging, 28(8): 1206-14. [Abstract] [Full-text]
10. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease.
    Neurobiol Aging, 28(8): 1239-47. [Abstract] [Full-text]
11. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice.
    Neurobiol Aging, 28(8): 1248-57. [Abstract] [Full-text]
12. Impact of the matrix metalloproteinase MMP-3 on dementia.
    Neurobiol Aging, 28(8): 1215-20. [Abstract] [Full-text]
13. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients.
    Neurobiol Aging, 28(8): 1163-9. [Abstract] [Full-text]
14. Short latency afferent inhibition is not impaired in mild cognitive impairment.
    Clin Neurophysiol, 118(7): 1460-3. [Abstract] [Full-text]
15. Cardiovascular risk factors in cognitively impaired nursing home patients: a relationship with pain?
    Eur J Pain, 11(6): 707-10. [Abstract] [Full-text]
16. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology.
    J Clin Invest, 117(6): 1595-604. [Abstract] [Full-text]
17. A beneficial role for IL-1 beta in Alzheimer disease?
    J Clin Invest, 117(6): 1483-5. [Abstract] [Full-text]
18. Autophagocytosis of mitochondria is prominent in Alzheimer disease.
    J Neuropathol Exp Neurol, 66(6): 525-32. [Abstract] [Full-text]
19. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
    J Neuropathol Exp Neurol, 66(6): 469-80. [Abstract] [Full-text]
20. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.
    Neurology, 68(23): 2012-8. [Abstract] [Full-text]
21. Cognitive assessment of older primary care patients with and without memory complaints.
    J Gen Intern Med, 22(7): 949-54. [Abstract] [Full-text]
22. Does this patient have dementia?
    JAMA, 297(21): 2391-404. [Abstract] [Full-text]
23. Validation of the Cognitive Assessment of Later Life Status (CALLS) instrument: a computerized telephonic measure.
    BMC Neurol, 7: 10. [Abstract] [Full-text]
24. Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community.
    Dement Geriatr Cogn Disord, 23(6): 439-45. [Abstract] [Full-text]
25. Sigma receptor type 1 gene variation in a group of Polish patients with Alzheimer's disease and mild cognitive impairment.
    Dement Geriatr Cogn Disord, 23(6): 432-8. [Abstract] [Full-text]
26. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
    Dement Geriatr Cogn Disord, 23(6): 423-31. [Abstract] [Full-text]
27. Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study.
    Dement Geriatr Cogn Disord, 23(6): 416-22. [Abstract] [Full-text]
28. Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study.
    Dement Geriatr Cogn Disord, 23(6): 406-15. [Abstract] [Full-text]
29. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Dement Geriatr Cogn Disord, 23(6): 401-5. [Abstract] [Full-text]
30. A Kantian moral duty for the soon-to-be demented to commit suicide.
    Am J Bioeth, 7(6): 37-44. [Abstract] [Full-text]
31. Deformation-based morphometry reveals brain atrophy in frontotemporal dementia.
    Arch Neurol, 64(6): 873-7. [Abstract] [Full-text]
32. Application of automated medial temporal lobe atrophy scale to Alzheimer disease.
    Arch Neurol, 64(6): 849-54. [Abstract] [Full-text]
33. Accuracy of the clinical evaluation for frontotemporal dementia.
    Arch Neurol, 64(6): 830-5. [Abstract] [Full-text]
34. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Arch Neurol, 64(6): 813-9. [Abstract] [Full-text]
35. Neural transplantation in Huntington disease: long-term grafts in two patients.
    Neurology, 68(24): 2093-8. [Abstract] [Full-text]
36. Activities of daily living in frontotemporal dementia and Alzheimer disease.
    Neurology, 68(24): 2077-84. [Abstract] [Full-text]
37. Neurophysiologic analyses of low- and high-level visual processing in Alzheimer disease.
    Neurology, 68(24): 2066-76. [Abstract] [Full-text]
38. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Expert Rev Neurother, 7(6): 735-48. [Abstract] [Full-text]
39. Long-term outcome of depressive pseudodementia in the elderly.
    J Affect Disord, 101(1): 123-9. [Abstract] [Full-text]
40. Systematic review of the effect of psychological interventions on family caregivers of people with dementia.
    J Affect Disord, 101(1): 75-89. [Abstract] [Full-text]
41. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
    Biochem Biophys Res Commun, 359(2): 335-40. [Abstract] [Full-text]
42. Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry, 78(7): 735-7. [Abstract] [Full-text]
43. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes.
    J Neurol Neurosurg Psychiatry, 78(7): 754-6. [Abstract] [Full-text]
44. Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
    J Neurol Neurosurg Psychiatry, 78(7): 733-4. [Abstract] [Full-text]
45. Visual recognition memory differentiates dementia with Lewy bodies and Parkinson's disease dementia.
    J Neurol Neurosurg Psychiatry, 78(7): 738-41. [Abstract] [Full-text]
46. Autonomic dysfunction in dementia.
    J Neurol Neurosurg Psychiatry, 78(7): 671-7. [Abstract] [Full-text]
47. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro.
    Biochem Biophys Res Commun, 359(3): 697-702. [Abstract] [Full-text]
48. Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects.
    Neuroimage, 36(3): 497-510. [Abstract] [Full-text]
49. Posterior reversible encephalopathy syndrome in a patient with severe preeclampsia.
    Anesth Analg, 105(1): 184-6. [Abstract] [Full-text]
50. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease.
    Glia, 55(10): 1074-84. [Abstract] [Full-text]
51. Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis.
    J Neurosci, 27(25): 6771-80. [Abstract] [Full-text]
52. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease.
    Brain, 130: 1732-44. [Abstract] [Full-text]
53. Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
    Brain, 130: 1745-58. [Abstract] [Full-text]
54. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Brain, 130: 1777-86. [Abstract] [Full-text]
55. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Brain, 130: 1767-76. [Abstract] [Full-text]
56. Microglial activation in presymptomatic Huntington's disease gene carriers.
    Brain, 130: 1759-66. [Abstract] [Full-text]
57. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
    BMC Neurol, 7: 14. [Abstract] [Full-text]
58. Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study.
    Stroke, 38(7): 2041-7. [Abstract] [Full-text]
59. Phenserine.
    Expert Opin Investig Drugs, 16(7): 1087-97. [Abstract] [Full-text]
60. Alzheimer-like changes in rat models of spontaneous diabetes.
    Diabetes, 56(7): 1817-24. [Abstract] [Full-text]
61. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    J Phys Chem B, 111(26): 7646-55. [Abstract] [Full-text]

© 2004-2008 Dementia Research Today. All Rights Reserved.